期刊
ACTA PHARMACEUTICA SINICA B
卷 2, 期 3, 页码 238-245出版社
INST MATERIA MEDICA, CHINESE ACAD MEDICAL SCIENCES
DOI: 10.1016/j.apsb.2012.03.009
关键词
Heat shock protein 90 (Hsp90); Tumor; Hsp90 inhibitors; Geldanamycin
资金
- National Science Foundation of China [90913020, 30901847]
- Science and Technology Program of China [2012ZX09103-101-053]
- Science and Technology Star of Zhujiang of Guangzhou City
Heat shock protein 90(Hsp90) is a highly conserved molecular chaperone that plays a vital role in the signal transduction of cancers. Hsp90 inhibitors are able to inhibit Hsp90 or the complex of Hsp90 and co-chaperones resulting in the degradation of Hsp90-dependent client proteins through the ubiquitination-proteasome pathway, thereby leading to the growth inhibition of tumor cells. This review will briefly discuss the molecular structure and biological function of Hsp90, and focus on a summary of recent progress in the development and testing of natural Hsp90 inhibitors and their different means by which they interact with Hsp90. (C) 2012 Institute of Materia Medica, Chinese Academy of Medical Sciences and Chinese Pharmaceutical Association. Production and hosting by Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据